Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03256968 · ClinicalTrials.gov registry record · Phase 4
PTC Study to Evaluate Ataluren in Combination With Ivacaftor
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT03256968 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 1 participants.
The verdict
NCT03256968, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the combination of ataluren and ivacaftor as a treatment for patients with nonsense mutation cystic fibrosis
Interventions
- DRUG Ataluren
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-01-27 |
| Est. Completion | 2018-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03256968
The ClinicalTrials.gov registry entry for NCT03256968 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ataluren is the first listed.
NCT03256968 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03256968 about?
NCT03256968 is a clinical study titled "PTC Study to Evaluate Ataluren in Combination With Ivacaftor". The purpose of this study is to explore the combination of ataluren and ivacaftor as a treatment for patients with nonsense mutation cystic fibrosis
What is the current status of trial NCT03256968?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2017-01-27. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03256968?
The interventions under investigation include: Ataluren (DRUG).
Who is sponsoring clinical trial NCT03256968?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.